Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Xenon Pharmaceuticals Profit Margin 2012-2020 | XENE

Current and historical gross margin, operating margin and net profit margin for Xenon Pharmaceuticals (XENE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Xenon Pharmaceuticals net profit margin as of September 30, 2020 is -91.91%.
  
Xenon Pharmaceuticals Annual Profit Margins
Xenon Pharmaceuticals Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.399B $0.007B
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.663B 10.17
Amgen (AMGN) United States $130.877B 13.68
CSL (CSLLY) Australia $102.723B 0.00
Gilead Sciences (GILD) United States $75.249B 10.01
Vertex Pharmaceuticals (VRTX) United States $58.953B 27.41
Regeneron Pharmaceuticals (REGN) United States $54.852B 19.46
Moderna (MRNA) United States $50.267B 0.00
Illumina (ILMN) United States $46.286B 63.66
Biogen (BIIB) United States $37.513B 6.66
Seagen (SGEN) United States $30.493B 80.53
Alexion Pharmaceuticals (ALXN) United States $27.100B 10.80
BeiGene (BGNE) Cayman Islands $25.958B 0.00
BioNTech SE (BNTX) Germany $24.887B 0.00
Genmab (GMAB) Denmark $24.337B 28.78
Genmab (GNMSF) Denmark $23.134B 5.33
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $18.231B 0.00
Exact Sciences (EXAS) United States $17.779B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.674B 59.44
Horizon Therapeutics Public (HZNP) Ireland $15.571B 22.26
Alnylam Pharmaceuticals (ALNY) United States $15.087B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.595B 96.87
ARGENX SE-ADR (ARGX) Netherlands $13.237B 0.00
Guardant Health (GH) United States $11.863B 0.00
Mirati Therapeutics (MRTX) United States $11.692B 0.00
Bio-Techne Corp (TECH) United States $11.492B 73.49
QIAGEN (QGEN) Netherlands $11.044B 24.87
Sarepta Therapeutics (SRPT) United States $10.981B 0.00
Repligen (RGEN) United States $9.839B 139.54
ACADIA Pharmaceuticals (ACAD) United States $8.903B 0.00
Ascendis Pharma (ASND) Denmark $8.788B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.588B 0.00
Galapagos (GLPG) Belgium $8.222B 0.00
Novavax (NVAX) United States $8.001B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.473B 0.00
Denali Therapeutics (DNLI) United States $7.347B 0.00
Acceleron Pharma (XLRN) United States $7.095B 0.00
Adaptive Biotechnologies (ADPT) United States $6.428B 0.00
Amicus Therapeutics (FOLD) United States $6.056B 0.00
Exelixis (EXEL) United States $6.022B 40.44
Blueprint Medicines (BPMC) United States $5.978B 19.79
Halozyme Therapeutics (HALO) United States $5.438B 251.44
SWEDISH ORP BIO (BIOVF) Sweden $5.355B 14.63
Reata Pharmaceuticals (RETA) United States $5.328B 0.00
NeoGenomics (NEO) United States $5.258B 1578.67
Twist Bioscience (TWST) United States $5.122B 0.00
Fate Therapeutics (FATE) United States $5.053B 0.00
China Biologic Products (CBPO) China $4.682B 30.34
Emergent Biosolutions (EBS) United States $4.390B 14.40
Insmed (INSM) United States $4.054B 0.00
Arena Pharmaceuticals (ARNA) United States $3.833B 0.00
Vir Biotechnology (VIR) United States $3.776B 0.00
Legend Biotech (LEGN) United States $3.748B 0.00
MorphoSys AG (MOR) Germany $3.706B 134.14
Deciphera Pharmaceuticals (DCPH) United States $3.550B 0.00
Eidos Therapeutics (EIDX) United States $3.480B 0.00
Alkermes (ALKS) Ireland $2.944B 28.91
Bluebird Bio (BLUE) United States $2.924B 0.00
Global Blood Therapeutics (GBT) United States $2.775B 0.00
Beam Therapeutics (BEAM) United States $2.763B 0.00
Seres Therapeutics (MCRB) United States $2.647B 0.00
Intellia Therapeutics (NTLA) United States $2.327B 0.00
Zymeworks (ZYME) Canada $2.285B 0.00
Viela Bio (VIE) United States $2.164B 0.00
Sorrento Therapeutics (SRNE) United States $2.143B 0.00
I-Mab (IMAB) China $2.127B 0.00
PHARMA MAR SA (PHMMF) Spain $2.120B 0.00
UniQure (QURE) Netherlands $2.102B 0.00
Inovio Pharmaceuticals (INO) United States $2.077B 0.00
Intra-Cellular Therapies (ITCI) United States $2.002B 0.00
Editas Medicine (EDIT) United States $1.954B 0.00
Alcobra (ARCT) United States $1.861B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.842B 0.00
Amarin (AMRN) Ireland $1.799B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.752B 0.00
Mesoblast (MESO) Australia $1.752B 0.00
Mersana Therapeutics (MRSN) United States $1.720B 0.00
Arcus Biosciences (RCUS) United States $1.669B 0.00
Revance Therapeutics (RVNC) United States $1.650B 0.00
NGM Biopharmaceuticals (NGM) United States $1.646B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Scholar Rock Holding (SRRK) United States $1.578B 0.00
Zealand Pharma (ZEAL) Denmark $1.497B 0.00
Sangamo Therapeutics (SGMO) United States $1.431B 0.00
Precigen (PGEN) United States $1.389B 0.00
REGENXBIO (RGNX) United States $1.386B 0.00
Ligand Pharmaceuticals (LGND) United States $1.382B 35.80
Adverum Biotechnologies (ADVM) United States $1.374B 0.00
Coherus BioSciences (CHRS) United States $1.342B 8.87
Myriad Genetics (MYGN) United States $1.337B 0.00
Athenex (ATNX) United States $1.300B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Epizyme (EPZM) United States $1.232B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.230B 0.00
Cytokineticsorporated (CYTK) United States $1.214B 0.00
Travere Therapeutics (TVTX) United States $1.214B 0.00
Genetron Holdings (GTH) China $1.213B 0.00
Heska (HSKA) United States $1.205B 0.00
Pliant Therapeutics (PLRX) United States $1.170B 0.00
Vericel (VCEL) United States $1.145B 0.00
Codexis (CDXS) United States $1.068B 0.00
Alector (ALEC) United States $1.053B 0.00
NantKwest (NK) United States $1.050B 0.00
Cellectis S.A (CLLS) France $1.029B 0.00
Arvinas (ARVN) United States $1.007B 0.00
Morphic Holding (MORF) United States $0.998B 0.00
Northwest Biotherapeutics (NWBO) United States $0.997B 0.00
Frequency Therapeutics (FREQ) United States $0.969B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.935B 0.00
Protagonist Therapeutics (PTGX) United States $0.912B 0.00
Celldex Therapeutics (CLDX) United States $0.900B 0.00
Compugen (CGEN) Israel $0.889B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.888B 0.00
Castle Biosciences (CSTL) United States $0.885B 0.00
Pharming Group (PHGUF) Netherlands $0.864B 19.71
Cardiff Oncology (CRDF) United States $0.774B 0.00
Cara Therapeutics (CARA) United States $0.745B 0.00
MiMedx (MDXG) United States $0.737B 0.00
Five Prime Therapeutics (FPRX) United States $0.725B 0.00
MannKind (MNKD) United States $0.716B 0.00
Kadmon Holdings (KDMN) United States $0.707B 0.00
Agenus (AGEN) United States $0.705B 0.00
AnaptysBio (ANAB) United States $0.705B 0.00
VBI Vaccines (VBIV) United States $0.702B 0.00
Albireo Pharma (ALBO) United States $0.693B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.679B 34.47
Sutro Biopharma (STRO) United States $0.660B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.653B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.639B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.638B 0.00
Precision BioSciences (DTIL) United States $0.626B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.624B 0.00
IVERIC Bio (ISEE) United States $0.593B 0.00
Geron (GERN) United States $0.581B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.563B 0.00
Anika Therapeutics (ANIK) United States $0.544B 73.60
MeiraGTx Holdings (MGTX) United States $0.534B 0.00
Dynavax Technologies (DVAX) United States $0.528B 0.00
Avid Bioservices (CDMO) United States $0.506B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.502B 0.00
Merus (MRUS) Netherlands $0.480B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.476B 0.00
Forte Biosciences (FBRX) United States $0.473B 0.00
Puma Biotechnology (PBYI) United States $0.466B 0.00
Spero Therapeutics (SPRO) United States $0.455B 0.00
WAVE Life Sciences (WVE) Singapore $0.452B 0.00
Prothena (PRTA) Ireland $0.451B 0.00
Innate Pharma S.A (IPHA) France $0.439B 0.00
Amryt Pharma (AMYT) United Kingdom $0.434B 0.00
UROGEN PHARMA (URGN) United States $0.428B 0.00
Clovis Oncology (CLVS) United States $0.420B 0.00
Cue Biopharma (CUE) United States $0.416B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.413B 0.00
Kala Pharmaceuticals (KALA) United States $0.409B 0.00
Starpharma Holdings (SPHRY) Australia $0.405B 0.00
Trevena (TRVN) United States $0.404B 0.00
Affimed (AFMD) Germany $0.403B 0.00
AC Immune SA (ACIU) Switzerland $0.400B 0.00
BioDelivery Sciences (BDSI) United States $0.386B 18.19
Athersys (ATHX) United States $0.376B 0.00
Syros Pharmaceuticals (SYRS) United States $0.373B 0.00
Selecta Biosciences (SELB) United States $0.369B 0.00
Arbutus Biopharma (ABUS) United States $0.369B 0.00
ANI Pharmaceuticals (ANIP) United States $0.364B 9.27
Cellular Biomedicine (CBMG) United States $0.364B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.362B 0.00
XOMA (XOMA) United States $0.353B 0.00
CytomX Therapeutics (CTMX) United States $0.343B 0.00
Verastem (VSTM) United States $0.338B 0.00
ChromaDex (CDXC) United States $0.310B 0.00
Kamada (KMDA) Israel $0.303B 14.17
PDL BioPharma (PDLI) United States $0.296B 0.00
NextCure (NXTC) United States $0.286B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.283B 0.00
DBV Technologies S.A (DBVT) France $0.280B 0.00
Fortress Biotech (FBIO) United States $0.260B 0.00
Pluristem Therapeutics (PSTI) Israel $0.246B 0.00
HOOKIPA Pharma (HOOK) United States $0.242B 0.00
Aptinyx (APTX) United States $0.241B 0.00
TELA Bio (TELA) United States $0.240B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Eton Pharmaceuticals (ETON) United States $0.193B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.190B 0.00
Cerecor (CERC) United States $0.189B 0.00
AquaBounty Technologies (AQB) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Bellus Health (BLU) Canada $0.184B 0.00
Aptevo Therapeutics (APVO) United States $0.184B 0.00
Theratechnologies (THTX) Canada $0.180B 0.00
ADMA Biologics Inc (ADMA) United States $0.180B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.163B 0.00
Biofrontera AG (BFRA) Germany $0.162B 0.00
Checkpoint Therapeutics (CKPT) United States $0.161B 0.00
Dyadic (DYAI) United States $0.159B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
SESEN BIO, INC (SESN) United States $0.157B 0.00
Oncobiologics (OTLK) United States $0.156B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.156B 0.00
Kindred Biosciences (KIN) United States $0.154B 0.00
Idera Pharmaceuticals (IDRA) United States $0.151B 0.00
Exicure (XCUR) United States $0.140B 0.00
Celyad SA (CYAD) Belgium $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.131B 0.00
Cocrystal Pharma (COCP) United States $0.130B 0.00
Lumos Pharma (LUMO) United States $0.124B 0.00
Gritstone Oncology (GRTS) United States $0.123B 0.00
TRACON Pharmaceuticals (TCON) United States $0.121B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Orgenesis (ORGS) United States $0.120B 247.50
Aytu Bioscience (AYTU) United States $0.118B 0.00
Liquidia Technologies (LQDA) United States $0.114B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Applied Genetic Technologies (AGTC) United States $0.112B 0.00
Cogent Biosciences (COGT) United States $0.112B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.111B 0.00
DiaMedica Therapeutics (DMAC) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.102B 0.00
Prometic Life Sciences (LMNL) Canada $0.098B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
Novogen (KZIA) Australia $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Synlogic (SYBX) United States $0.087B 0.00
Curis (CRIS) United States $0.085B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.077B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.076B 0.00
Evogene (EVGN) Israel $0.076B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
AnPac Bio-Medical Science (ANPC) China $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 32.75
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Soligenix (SNGX) United States $0.065B 0.00
Appili Therapeutics (APLIF) Canada $0.061B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Emmaus Life Sciences (EMMA) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.057B 0.00
Seelos Therapeutics (SEEL) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Edesa Biotech (EDSA) Canada $0.050B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Cleveland BioLabs (CBLI) United States $0.047B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
OvaScience (MLND) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Titan Pharmaceuticals (TTNP) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.032B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Spherix (AIKI) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00